After a series of delays throughout last year due to the ongoing coronavirus pandemic, Sony Pictures has decided to move back Daniel Espinosa's Morbius one more week, this time from January 21 to January 28, 2022.
However, unlike the previous pandemic-related postponements, this time it's for a good reason. The film has officially been confirmed for an IMAX release, which should make a notable difference at the global box office come next January.
Morbius will now open opposite Universal/Blumhouse's The Black Phone, which has Scott Derrickson (Doctor Strange) directing and Ethan Hawke (Moon Knight) playing the lead.
The move also creates some much-needed space away from the massive January 14 logjam that is currently slated to see Universal's The 355 starring Jessica Chastain and Penélope Cruz; 20th Century Studios' Deep Water starring Ben Affleck and Ana de Armas; Paramount's Scream starring Neve Campbell and Courteney Cox; Warner Bros.' Sesame Street starring Anne Hathaway and Chance the Rapper; and Sony's The Man from Toronto starring Kevin Hart and Woody Harrelson all opening on the same day.
The upcoming Spider-Man spinoff stars Academy Award-winner Jared Leto (Blade Runner 2049; Suicide Squad) in the title role with a supporting cast that contains Matt Smith (Terminator: Genisys; Doctor Who), Adria Arjona (6 Underground; Triple Frontier), Jared Harris (The Man from U.N.C.L.E.; Chernobyl), Al Madrigal (I'm Dying Up Here; About a Boy), Tyrese Gibson (F9; Transformers), and Michael Keaton (Spider-Man: Homecoming; Batman) as the Vulture.
One of Marvel’s most compelling and conflicted characters comes to the big screen as Oscar® winner Jared Leto transforms into the enigmatic antihero, Michael Morbius. Dangerously ill with a rare blood disorder, and determined to save others suffering his same fate, Dr. Morbius attempts a desperate gamble. What at first appears to be a radical success, a darkness inside him is unleashed and transforms this healer into a hunter.
ComicBookMovie.com, and/or the user who contributed this post, may earn commissions or revenue through clicks or purchases made through any third-party links contained within the content above.